ذهان منبه (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "ذهان منبه" in Arabic language version.

refsWebsite

Global rank Arabic rank

35nih.gov

4^th place

6^th place

26doi.org

2^nd place

5^th place

11semanticscholar.org

11^th place

86^th place

5web.archive.org

1^st place

2handle.net

102^nd place

452^nd place

1fda.gov

447^th place

393^rd place

1harvard.edu

18^th place

33^rd place

1books.google.com

3^rd place

8^th place

1medscape.com

719^th place

243^rd place

1archive.org

6^th place

3^rd place

1fmhac.net

low place

archive.org

DiSCLAFANI؛ وآخرون (1981). "Drug-induced psychosis: Emergency diagnosis and management". Psychosomatics. ج. 22 ع. 10: 845–855. DOI:10.1016/s0033-3182(81)73092-5. PMID:7313045.

books.google.com

Alan F. Schatzberg؛ Charles B. Nemeroff (2009). The American Psychiatric Publishing Textbook of Psychopharmacology. The American Psychiatric Publishing. ص. 847–48. ISBN:978-1-58562-309-9. مؤرشف من الأصل في 2021-08-02.

doi.org

Shoptaw، Steven J؛ Kao، Uyen؛ Ling، Walter (21 يناير 2009). "Treatment for amphetamine psychosis". Cochrane Database of Systematic Reviews ع. 1: CD003026. DOI:10.1002/14651858.CD003026.pub3. PMC:7004251. PMID:19160215.
Mosholder AD، Gelperin K، Hammad TA، Phelan K، Johann-Liang R (فبراير 2009). "Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children". Pediatrics. ج. 123 ع. 2: 611–616. DOI:10.1542/peds.2008-0185. PMID:19171629. S2CID:22391693.
Greening، David W.؛ Notaras، Michael؛ Chen، Maoshan؛ Xu، Rong؛ Smith، Joel D.؛ Cheng، Lesley؛ Simpson، Richard J.؛ Hill، Andrew F.؛ van den Buuse، Maarten (10 ديسمبر 2019). "Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome". Molecular Psychiatry. DOI:10.1038/s41380-019-0617-8. PMID:31822818. S2CID:209169489.
Shoptaw SJ، Kao U، Ling W (2009). "Treatment for amphetamine psychosis (Review)". Cochrane Database of Systematic Reviews. ج. 2009 ع. 1: 1. DOI:10.1002/14651858.cd003026.pub3. PMC:7004251. PMID:19160215.
Dore G، Sweeting M (2006). "Drug-induced psychosis associated with crystalline methamphetamine". Australasian Psychiatry. ج. 14 ع. 1: 86–9. DOI:10.1080/j.1440-1665.2006.02252.x. PMID:16630206. S2CID:196398062.
Srisurapanont M، Ali R، Marsden J، Sunga A، Wada K، Monteiro M (2003). "Psychotic symptoms in methamphetamine psychotic in-patients". International Journal of Neuropsychopharmacology. ج. 6 ع. 4: 347–52. DOI:10.1017/s1461145703003675. PMID:14604449.
Sato M، Numachi Y، Hamamura T (1992). "Relapse of paranoid psychotic state in methamphetamine model of schizophrenia". Schizophrenia Bulletin. ج. 18 ع. 1: 115–22. DOI:10.1093/schbul/18.1.115. PMID:1553491.
Yui K، Ikemoto S، Goto K (2002). "Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis". Annals of the New York Academy of Sciences. ج. 965 ع. 1: 292–304. Bibcode:2002NYASA.965..292Y. DOI:10.1111/j.1749-6632.2002.tb04171.x. PMID:12105105. S2CID:25830663.
Chen CK، Lin SK، Pak CS، Ball D، Loh EW، Murray RM (2005). "Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis". American Journal of Medical Genetics Part B. ج. 136 ع. 1: 87–91. DOI:10.1002/ajmg.b.30187. PMID:15892150. S2CID:25135637.
Sarampote CS، Efron LA، Robb AS، Pearl PL، Stein MA (2002). "Can stimulant rebound mimic pediatric bipolar disorder?". J Child Adolesc Psychopharmacol. ج. 12 ع. 1: 63–7. DOI:10.1089/10445460252943588. PMID:12014597.
Hegerl U، Sander C، Olbrich S، Schoenknecht P (أغسطس 2006). "Are psychostimulants a treatment option in mania?". Prog Neuropsychopharmacol Biol Psychiatry. ج. 30 ع. 6: 1097–102. DOI:10.1016/j.pnpbp.2006.04.016. PMID:16740350. S2CID:13239942.
Thirthalli J.؛ Vivek B. (2006). "Psychosis Among Substance Users". Curr Opin Psychiatry. ج. 19 ع. 3: 239–245. DOI:10.1097/01.yco.0000218593.08313.fd. PMID:16612208. S2CID:13350537. مؤرشف من الأصل في 2020-11-11.
Elliott A.؛ Mahmood T.؛ Smalligan R. D. (2012). "Cocaine Bugs: A Case Report of Cocaine-Induced Delusions of Parasitosis". The American Journal on Addictions. ج. 21 ع. 2: 180–181. DOI:10.1111/j.1521-0391.2011.00208.x. PMID:22332864.
DiSCLAFANI؛ وآخرون (1981). "Drug-induced psychosis: Emergency diagnosis and management". Psychosomatics. ج. 22 ع. 10: 845–855. DOI:10.1016/s0033-3182(81)73092-5. PMID:7313045.
Robins، Meridith T.؛ Blaine، Arryn T.؛ Ha، Jiwon E.؛ Brewster، Amy L.؛ Van Rijn، Richard M. (2019). "Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice". Frontiers in Neuroscience. ج. 13: 124. DOI:10.3389/fnins.2019.00124. PMC:6389692. PMID:30837836.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
McLaughlin، G.؛ Morris، N.؛ Kavanagh، P. V.؛ Power، J. D.؛ Dowling، G.؛ Twamley، B.؛ O'Brien، J.؛ Hessman، G.؛ Murphy، B.؛ Walther، D.؛ Partilla، J. S.؛ Baumann، M. H.؛ Brandt، S. D. (2017). "Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo- and (±)-erythro- diastereomers". Drug Testing and Analysis. ج. 9 ع. 3: 347–357. DOI:10.1002/dta.2167. PMC:5378611. PMID:28103426.
Markowitz، J. S.؛ Zhu، H. J.؛ Patrick، K. S. (2013). "Isopropylphenidate: An ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability". Journal of Child and Adolescent Psychopharmacology. ج. 23 ع. 10: 648–54. DOI:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID:24261661.
Morton WA، Stockton GG (2000). "Methylphenidate abuse and psychiatric side effects". Prim Care Companion J Clin Psychiatry. ج. 2 ع. 5: 159–64. DOI:10.4088/pcc.v02n0502. PMC:181133. PMID:15014637.
Spensley J، Rockwell D (أبريل 1972). "Psychosis during methylphenidate Abuse". New England Journal of Medicine. ج. 286 ع. 16: 880–1. DOI:10.1056/NEJM197204202861607. PMID:5061074.
Robertson، Roy (2017). "Prolonged mental health effects of ethylphenidate beyond cessation of use". Addiction. ج. 112 ع. 1: 183–184. DOI:10.1111/add.13630. PMID:27936504.
McLaughlin، Gavin؛ Morris، Noreen؛ Kavanagh، Pierce V.؛ Power، John D.؛ Dowling، Geraldine؛ Twamley، Brendan؛ O'Brien، John؛ Hessman، Gary؛ Murphy، Brian؛ Walther، Donna؛ Partilla، John S.؛ Baumann، Michael H.؛ Brandt، Simon D. (مارس 2017). "Analytical characterization and pharmacological evaluation of the new psychoactive substance 4‐fluoromethylphenidate (4F‐MPH) and differentiation between the (±)‐threo and (±)‐erythro diastereomers". Drug Testing and Analysis. ج. 9 ع. 3: 347–357. DOI:10.1002/dta.2167. PMC:5378611. PMID:28103426.
Markowitz، John S.؛ Zhu، Hao-Jie؛ Patrick، Kennerly S. (ديسمبر 2013). "Isopropylphenidate: An Ester Homolog of Methylphenidate with Sustained and Selective Dopaminergic Activity and Reduced Drug Interaction Liability". Journal of Child and Adolescent Psychopharmacology. ج. 23 ع. 10: 648–654. DOI:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID:24261661.
Hedges، D. W.؛ F. L. Woon؛ S. P. Hoopes (سبتمبر 2009). "Caffeine-induced psychosis". CNS Spectrums. ج. 14 ع. 3: 127–9. DOI:10.1017/S1092852900020101. PMID:19407709. S2CID:32188625.
Cerimele، Joseph M.؛ Stern، Adam P.؛ Jutras-Aswad، Didier (مارس 2010). "Psychosis Following Excessive Ingestion of Energy Drinks in a Patient With Schizophrenia". American Journal of Psychiatry. ج. 167 ع. 3: 353. DOI:10.1176/appi.ajp.2009.09101456. PMID:20194494. S2CID:5832823. مؤرشف من الأصل في 2021-04-29.
Murrie، Benjamin؛ Lappin، Julia؛ Large، Matthew؛ Sara، Grant (16 أكتوبر 2019). "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis". Schizophrenia Bulletin. ج. 46 ع. 3: 505–516. DOI:10.1093/schbul/sbz102. PMC:7147575. PMID:31618428.
Penders، T. M.؛ Lang، M. C.؛ Pagano، J. J.؛ Gooding، Z. S. (2013). "Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone ("bath salts")". The Journal of ECT. ج. 29 ع. 4: e59-60. DOI:10.1097/YCT.0b013e3182887bc2. PMID:23609518. S2CID:45842375.

fda.gov

accessdata.fda.gov

"Adderall XR Prescribing Information" (PDF). United States Food and Drug Administration. Shire US Inc. ديسمبر 2013. مؤرشف من الأصل (PDF) في 2021-06-22. اطلع عليه بتاريخ 2013-12-30. Treatment-emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without prior history of psychotic illness or mania can be caused by stimulants at usual doses. ... In a pooled analysis of multiple short-term, placebo controlled studies, such symptoms occurred in about 0.1% (4 patients with events out of 3482 exposed to methylphenidate or amphetamine for several weeks at usual doses) of stimulant-treated patients compared to 0 in placebo-treated patients.

fmhac.net

"White Paper Report on Excited Delirium Syndrome" نسخة محفوظة 22 يوليو 2018 على موقع واي باك مشين. , ACEP Excited Delirium Task Force, American College of Emergency Physicians, 10 September 2009 "نسخة مؤرشفة" (PDF). مؤرشف من الأصل في 2018-07-22. اطلع عليه بتاريخ 2021-08-02.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)

handle.net

hdl.handle.net

Markowitz، J. S.؛ Zhu، H. J.؛ Patrick، K. S. (2013). "Isopropylphenidate: An ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability". Journal of Child and Adolescent Psychopharmacology. ج. 23 ع. 10: 648–54. DOI:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID:24261661.
Markowitz، John S.؛ Zhu، Hao-Jie؛ Patrick، Kennerly S. (ديسمبر 2013). "Isopropylphenidate: An Ester Homolog of Methylphenidate with Sustained and Selective Dopaminergic Activity and Reduced Drug Interaction Liability". Journal of Child and Adolescent Psychopharmacology. ج. 23 ع. 10: 648–654. DOI:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID:24261661.

harvard.edu

ui.adsabs.harvard.edu

Yui K، Ikemoto S، Goto K (2002). "Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis". Annals of the New York Academy of Sciences. ج. 965 ع. 1: 292–304. Bibcode:2002NYASA.965..292Y. DOI:10.1111/j.1749-6632.2002.tb04171.x. PMID:12105105. S2CID:25830663.

medscape.com

Thirthalli J.؛ Vivek B. (2006). "Psychosis Among Substance Users". Curr Opin Psychiatry. ج. 19 ع. 3: 239–245. DOI:10.1097/01.yco.0000218593.08313.fd. PMID:16612208. S2CID:13350537. مؤرشف من الأصل في 2020-11-11.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shoptaw، Steven J؛ Kao، Uyen؛ Ling، Walter (21 يناير 2009). "Treatment for amphetamine psychosis". Cochrane Database of Systematic Reviews ع. 1: CD003026. DOI:10.1002/14651858.CD003026.pub3. PMC:7004251. PMID:19160215.
Mosholder AD، Gelperin K، Hammad TA، Phelan K، Johann-Liang R (فبراير 2009). "Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children". Pediatrics. ج. 123 ع. 2: 611–616. DOI:10.1542/peds.2008-0185. PMID:19171629. S2CID:22391693.
Greening، David W.؛ Notaras، Michael؛ Chen، Maoshan؛ Xu، Rong؛ Smith، Joel D.؛ Cheng، Lesley؛ Simpson، Richard J.؛ Hill، Andrew F.؛ van den Buuse، Maarten (10 ديسمبر 2019). "Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome". Molecular Psychiatry. DOI:10.1038/s41380-019-0617-8. PMID:31822818. S2CID:209169489.
Shoptaw SJ، Kao U، Ling W (2009). "Treatment for amphetamine psychosis (Review)". Cochrane Database of Systematic Reviews. ج. 2009 ع. 1: 1. DOI:10.1002/14651858.cd003026.pub3. PMC:7004251. PMID:19160215.
Dore G، Sweeting M (2006). "Drug-induced psychosis associated with crystalline methamphetamine". Australasian Psychiatry. ج. 14 ع. 1: 86–9. DOI:10.1080/j.1440-1665.2006.02252.x. PMID:16630206. S2CID:196398062.
Srisurapanont M، Ali R، Marsden J، Sunga A، Wada K، Monteiro M (2003). "Psychotic symptoms in methamphetamine psychotic in-patients". International Journal of Neuropsychopharmacology. ج. 6 ع. 4: 347–52. DOI:10.1017/s1461145703003675. PMID:14604449.
Sato M، Numachi Y، Hamamura T (1992). "Relapse of paranoid psychotic state in methamphetamine model of schizophrenia". Schizophrenia Bulletin. ج. 18 ع. 1: 115–22. DOI:10.1093/schbul/18.1.115. PMID:1553491.
Yui K، Ikemoto S، Goto K (2002). "Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis". Annals of the New York Academy of Sciences. ج. 965 ع. 1: 292–304. Bibcode:2002NYASA.965..292Y. DOI:10.1111/j.1749-6632.2002.tb04171.x. PMID:12105105. S2CID:25830663.
Chen CK، Lin SK، Pak CS، Ball D، Loh EW، Murray RM (2005). "Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis". American Journal of Medical Genetics Part B. ج. 136 ع. 1: 87–91. DOI:10.1002/ajmg.b.30187. PMID:15892150. S2CID:25135637.
Sarampote CS، Efron LA، Robb AS، Pearl PL، Stein MA (2002). "Can stimulant rebound mimic pediatric bipolar disorder?". J Child Adolesc Psychopharmacol. ج. 12 ع. 1: 63–7. DOI:10.1089/10445460252943588. PMID:12014597.
Hegerl U، Sander C، Olbrich S، Schoenknecht P (أغسطس 2006). "Are psychostimulants a treatment option in mania?". Prog Neuropsychopharmacol Biol Psychiatry. ج. 30 ع. 6: 1097–102. DOI:10.1016/j.pnpbp.2006.04.016. PMID:16740350. S2CID:13239942.
Brady KT، Lydiard RB، Malcolm R، Ballenger JC (1991). "Cocaine-induced psychosis". J Clin Psychiatry. ج. 52 ع. 12: 509–512. PMID:1752853.
Thirthalli J.؛ Vivek B. (2006). "Psychosis Among Substance Users". Curr Opin Psychiatry. ج. 19 ع. 3: 239–245. DOI:10.1097/01.yco.0000218593.08313.fd. PMID:16612208. S2CID:13350537. مؤرشف من الأصل في 2020-11-11.
Elliott A.؛ Mahmood T.؛ Smalligan R. D. (2012). "Cocaine Bugs: A Case Report of Cocaine-Induced Delusions of Parasitosis". The American Journal on Addictions. ج. 21 ع. 2: 180–181. DOI:10.1111/j.1521-0391.2011.00208.x. PMID:22332864.
DiSCLAFANI؛ وآخرون (1981). "Drug-induced psychosis: Emergency diagnosis and management". Psychosomatics. ج. 22 ع. 10: 845–855. DOI:10.1016/s0033-3182(81)73092-5. PMID:7313045.
Robins، Meridith T.؛ Blaine، Arryn T.؛ Ha، Jiwon E.؛ Brewster، Amy L.؛ Van Rijn، Richard M. (2019). "Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice". Frontiers in Neuroscience. ج. 13: 124. DOI:10.3389/fnins.2019.00124. PMC:6389692. PMID:30837836.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
McLaughlin، G.؛ Morris، N.؛ Kavanagh، P. V.؛ Power، J. D.؛ Dowling، G.؛ Twamley، B.؛ O'Brien، J.؛ Hessman، G.؛ Murphy، B.؛ Walther، D.؛ Partilla، J. S.؛ Baumann، M. H.؛ Brandt، S. D. (2017). "Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo- and (±)-erythro- diastereomers". Drug Testing and Analysis. ج. 9 ع. 3: 347–357. DOI:10.1002/dta.2167. PMC:5378611. PMID:28103426.
Markowitz، J. S.؛ Zhu، H. J.؛ Patrick، K. S. (2013). "Isopropylphenidate: An ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability". Journal of Child and Adolescent Psychopharmacology. ج. 23 ع. 10: 648–54. DOI:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID:24261661.
Morton WA، Stockton GG (2000). "Methylphenidate abuse and psychiatric side effects". Prim Care Companion J Clin Psychiatry. ج. 2 ع. 5: 159–64. DOI:10.4088/pcc.v02n0502. PMC:181133. PMID:15014637.
Spensley J، Rockwell D (أبريل 1972). "Psychosis during methylphenidate Abuse". New England Journal of Medicine. ج. 286 ع. 16: 880–1. DOI:10.1056/NEJM197204202861607. PMID:5061074.
Robertson، Roy (2017). "Prolonged mental health effects of ethylphenidate beyond cessation of use". Addiction. ج. 112 ع. 1: 183–184. DOI:10.1111/add.13630. PMID:27936504.
McLaughlin، Gavin؛ Morris، Noreen؛ Kavanagh، Pierce V.؛ Power، John D.؛ Dowling، Geraldine؛ Twamley، Brendan؛ O'Brien، John؛ Hessman، Gary؛ Murphy، Brian؛ Walther، Donna؛ Partilla، John S.؛ Baumann، Michael H.؛ Brandt، Simon D. (مارس 2017). "Analytical characterization and pharmacological evaluation of the new psychoactive substance 4‐fluoromethylphenidate (4F‐MPH) and differentiation between the (±)‐threo and (±)‐erythro diastereomers". Drug Testing and Analysis. ج. 9 ع. 3: 347–357. DOI:10.1002/dta.2167. PMC:5378611. PMID:28103426.
Markowitz، John S.؛ Zhu، Hao-Jie؛ Patrick، Kennerly S. (ديسمبر 2013). "Isopropylphenidate: An Ester Homolog of Methylphenidate with Sustained and Selective Dopaminergic Activity and Reduced Drug Interaction Liability". Journal of Child and Adolescent Psychopharmacology. ج. 23 ع. 10: 648–654. DOI:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID:24261661.
Hedges، D. W.؛ F. L. Woon؛ S. P. Hoopes (سبتمبر 2009). "Caffeine-induced psychosis". CNS Spectrums. ج. 14 ع. 3: 127–9. DOI:10.1017/S1092852900020101. PMID:19407709. S2CID:32188625.
Cerimele، Joseph M.؛ Stern، Adam P.؛ Jutras-Aswad، Didier (مارس 2010). "Psychosis Following Excessive Ingestion of Energy Drinks in a Patient With Schizophrenia". American Journal of Psychiatry. ج. 167 ع. 3: 353. DOI:10.1176/appi.ajp.2009.09101456. PMID:20194494. S2CID:5832823. مؤرشف من الأصل في 2021-04-29.
Broderick، P.؛ Benjamin، A. B. (2004). "Caffeine and psychiatric symptoms: A review". The Journal of the Oklahoma State Medical Association. ج. 97 ع. 12: 538–542. PMID:15732884.
Murrie، Benjamin؛ Lappin، Julia؛ Large، Matthew؛ Sara، Grant (16 أكتوبر 2019). "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis". Schizophrenia Bulletin. ج. 46 ع. 3: 505–516. DOI:10.1093/schbul/sbz102. PMC:7147575. PMID:31618428.
Penders، T. M.؛ Lang، M. C.؛ Pagano، J. J.؛ Gooding، Z. S. (2013). "Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone ("bath salts")". The Journal of ECT. ج. 29 ع. 4: e59-60. DOI:10.1097/YCT.0b013e3182887bc2. PMID:23609518. S2CID:45842375.

ncbi.nlm.nih.gov

Shoptaw، Steven J؛ Kao، Uyen؛ Ling، Walter (21 يناير 2009). "Treatment for amphetamine psychosis". Cochrane Database of Systematic Reviews ع. 1: CD003026. DOI:10.1002/14651858.CD003026.pub3. PMC:7004251. PMID:19160215.
Shoptaw SJ، Kao U، Ling W (2009). "Treatment for amphetamine psychosis (Review)". Cochrane Database of Systematic Reviews. ج. 2009 ع. 1: 1. DOI:10.1002/14651858.cd003026.pub3. PMC:7004251. PMID:19160215.
Robins، Meridith T.؛ Blaine، Arryn T.؛ Ha، Jiwon E.؛ Brewster، Amy L.؛ Van Rijn، Richard M. (2019). "Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice". Frontiers in Neuroscience. ج. 13: 124. DOI:10.3389/fnins.2019.00124. PMC:6389692. PMID:30837836.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
McLaughlin، G.؛ Morris، N.؛ Kavanagh، P. V.؛ Power، J. D.؛ Dowling، G.؛ Twamley، B.؛ O'Brien، J.؛ Hessman، G.؛ Murphy، B.؛ Walther، D.؛ Partilla، J. S.؛ Baumann، M. H.؛ Brandt، S. D. (2017). "Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo- and (±)-erythro- diastereomers". Drug Testing and Analysis. ج. 9 ع. 3: 347–357. DOI:10.1002/dta.2167. PMC:5378611. PMID:28103426.
Morton WA، Stockton GG (2000). "Methylphenidate abuse and psychiatric side effects". Prim Care Companion J Clin Psychiatry. ج. 2 ع. 5: 159–64. DOI:10.4088/pcc.v02n0502. PMC:181133. PMID:15014637.
McLaughlin، Gavin؛ Morris، Noreen؛ Kavanagh، Pierce V.؛ Power، John D.؛ Dowling، Geraldine؛ Twamley، Brendan؛ O'Brien، John؛ Hessman، Gary؛ Murphy، Brian؛ Walther، Donna؛ Partilla، John S.؛ Baumann، Michael H.؛ Brandt، Simon D. (مارس 2017). "Analytical characterization and pharmacological evaluation of the new psychoactive substance 4‐fluoromethylphenidate (4F‐MPH) and differentiation between the (±)‐threo and (±)‐erythro diastereomers". Drug Testing and Analysis. ج. 9 ع. 3: 347–357. DOI:10.1002/dta.2167. PMC:5378611. PMID:28103426.
Murrie، Benjamin؛ Lappin، Julia؛ Large، Matthew؛ Sara، Grant (16 أكتوبر 2019). "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis". Schizophrenia Bulletin. ج. 46 ع. 3: 505–516. DOI:10.1093/schbul/sbz102. PMC:7147575. PMID:31618428.

semanticscholar.org

api.semanticscholar.org

Mosholder AD، Gelperin K، Hammad TA، Phelan K، Johann-Liang R (فبراير 2009). "Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children". Pediatrics. ج. 123 ع. 2: 611–616. DOI:10.1542/peds.2008-0185. PMID:19171629. S2CID:22391693.
Greening، David W.؛ Notaras، Michael؛ Chen، Maoshan؛ Xu، Rong؛ Smith، Joel D.؛ Cheng، Lesley؛ Simpson، Richard J.؛ Hill، Andrew F.؛ van den Buuse، Maarten (10 ديسمبر 2019). "Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome". Molecular Psychiatry. DOI:10.1038/s41380-019-0617-8. PMID:31822818. S2CID:209169489.
Dore G، Sweeting M (2006). "Drug-induced psychosis associated with crystalline methamphetamine". Australasian Psychiatry. ج. 14 ع. 1: 86–9. DOI:10.1080/j.1440-1665.2006.02252.x. PMID:16630206. S2CID:196398062.
Yui K، Ikemoto S، Goto K (2002). "Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis". Annals of the New York Academy of Sciences. ج. 965 ع. 1: 292–304. Bibcode:2002NYASA.965..292Y. DOI:10.1111/j.1749-6632.2002.tb04171.x. PMID:12105105. S2CID:25830663.
Chen CK، Lin SK، Pak CS، Ball D، Loh EW، Murray RM (2005). "Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis". American Journal of Medical Genetics Part B. ج. 136 ع. 1: 87–91. DOI:10.1002/ajmg.b.30187. PMID:15892150. S2CID:25135637.
Hegerl U، Sander C، Olbrich S، Schoenknecht P (أغسطس 2006). "Are psychostimulants a treatment option in mania?". Prog Neuropsychopharmacol Biol Psychiatry. ج. 30 ع. 6: 1097–102. DOI:10.1016/j.pnpbp.2006.04.016. PMID:16740350. S2CID:13239942.
Thirthalli J.؛ Vivek B. (2006). "Psychosis Among Substance Users". Curr Opin Psychiatry. ج. 19 ع. 3: 239–245. DOI:10.1097/01.yco.0000218593.08313.fd. PMID:16612208. S2CID:13350537. مؤرشف من الأصل في 2020-11-11.
Hedges، D. W.؛ F. L. Woon؛ S. P. Hoopes (سبتمبر 2009). "Caffeine-induced psychosis". CNS Spectrums. ج. 14 ع. 3: 127–9. DOI:10.1017/S1092852900020101. PMID:19407709. S2CID:32188625.
Cerimele، Joseph M.؛ Stern، Adam P.؛ Jutras-Aswad، Didier (مارس 2010). "Psychosis Following Excessive Ingestion of Energy Drinks in a Patient With Schizophrenia". American Journal of Psychiatry. ج. 167 ع. 3: 353. DOI:10.1176/appi.ajp.2009.09101456. PMID:20194494. S2CID:5832823. مؤرشف من الأصل في 2021-04-29.
Penders، T. M.؛ Lang، M. C.؛ Pagano، J. J.؛ Gooding، Z. S. (2013). "Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone ("bath salts")". The Journal of ECT. ج. 29 ع. 4: e59-60. DOI:10.1097/YCT.0b013e3182887bc2. PMID:23609518. S2CID:45842375.

semanticscholar.org

Cerimele، Joseph M.؛ Stern، Adam P.؛ Jutras-Aswad، Didier (مارس 2010). "Psychosis Following Excessive Ingestion of Energy Drinks in a Patient With Schizophrenia". American Journal of Psychiatry. ج. 167 ع. 3: 353. DOI:10.1176/appi.ajp.2009.09101456. PMID:20194494. S2CID:5832823. مؤرشف من الأصل في 2021-04-29.

web.archive.org

"Adderall XR Prescribing Information" (PDF). United States Food and Drug Administration. Shire US Inc. ديسمبر 2013. مؤرشف من الأصل (PDF) في 2021-06-22. اطلع عليه بتاريخ 2013-12-30. Treatment-emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without prior history of psychotic illness or mania can be caused by stimulants at usual doses. ... In a pooled analysis of multiple short-term, placebo controlled studies, such symptoms occurred in about 0.1% (4 patients with events out of 3482 exposed to methylphenidate or amphetamine for several weeks at usual doses) of stimulant-treated patients compared to 0 in placebo-treated patients.
Alan F. Schatzberg؛ Charles B. Nemeroff (2009). The American Psychiatric Publishing Textbook of Psychopharmacology. The American Psychiatric Publishing. ص. 847–48. ISBN:978-1-58562-309-9. مؤرشف من الأصل في 2021-08-02.
Thirthalli J.؛ Vivek B. (2006). "Psychosis Among Substance Users". Curr Opin Psychiatry. ج. 19 ع. 3: 239–245. DOI:10.1097/01.yco.0000218593.08313.fd. PMID:16612208. S2CID:13350537. مؤرشف من الأصل في 2020-11-11.
Cerimele، Joseph M.؛ Stern، Adam P.؛ Jutras-Aswad، Didier (مارس 2010). "Psychosis Following Excessive Ingestion of Energy Drinks in a Patient With Schizophrenia". American Journal of Psychiatry. ج. 167 ع. 3: 353. DOI:10.1176/appi.ajp.2009.09101456. PMID:20194494. S2CID:5832823. مؤرشف من الأصل في 2021-04-29.
"White Paper Report on Excited Delirium Syndrome" نسخة محفوظة 22 يوليو 2018 على موقع واي باك مشين. , ACEP Excited Delirium Task Force, American College of Emergency Physicians, 10 September 2009 "نسخة مؤرشفة" (PDF). مؤرشف من الأصل في 2018-07-22. اطلع عليه بتاريخ 2021-08-02.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)